MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wave of Debt Payments Facing US Government
- Why Amazon Rules Retail
- HP Comes in As Expected; Is It Time to Buy?
- JAL Slides to Record Low on Bankruptcy Jitters
- Paul: Audit the Fed
- Hewlett-Packard Profit Rises, Matches Guidance
- Prepare For Large Decline In Stocks, Next Year?
- The Social Media Gaming Threat
- Holiday Travel Outlook
- Obama says Boosting US Jobs is Top Priority
- More Consumers Giving 'Black Friday' the Cold Shoulder
- Prepare For Large Decline In Stocks, Next Year?
- Hewlett-Packard Earnings Rise, Match Guidance
- HP Comes in As Expected; Is It Time to Buy?
- Cramer: What Monday’s Housing Number Really Means
- Why the Dollar Will Likely Stay Weak for Some Time
- Bear, Lehman Execs Weren't Wiped Out by Crisis: Study
- How Real Estate Investors Skew Housing's Reality
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
ST. LOUIS, Nov 06, 2009 (BUSINESS WIRE) -- St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man who experienced partial respiratory paralysis and other side effects after receiving an overdose of the Botox being used to treat his muscle spasticity.
The suit, Richard A. Hart v. Yi Pan, Tenet HealthSystem SL Inc., d/b/a St. Louis University Hospital and Allergan USA Inc., cause no. 0922-CC09485, was filed in St. Louis Circuit Court on Oct. 21.
The plaintiff, Richard Hart, suffers from a medical condition affecting his neck known as torticollis. In an effort to relieve muscle spasticity, Dr. Yi Pan of the St. Louis VA Medical Center prescribed Botox, made by Allergan USA Inc.
(NYSE: AGN). Botox (onabotulinumtoxin A), produced by the bacterium that causes botulism, is highly toxic to humans.
Hart received 300 units of Botox on Aug. 20, 2007, 300 units on Sept. 20, 2007, and 400 units on Oct. 5, 2007. On Oct. 17, 2007, Hart reported breathing problems and difficulty swallowing; eventually partial paralysis of the respiratory muscles, general weakness, blurred vision, difficulty breathing and loss of the gag reflex developed as a result of the botulism poisoning.
On April 30, 2009, the U.S. Food and Drug Administration issued a news release announcing that a boxed warning would be required for the packaging of all botulinum toxin products, warning that toxins can spread from the injection site to other areas of the body, causing symptoms similar to those of botulism.
The lawsuit alleges that Dr. Pan was negligent because she failed to accurately monitor Hart's Botox doses, failed to adhere to the recommended dosage schedule, administered Botox in an unapproved treatment and failed to treat the overdose in a timely manner.
In his claim against Allergan, the patient alleges that the drug maker defectively designed and formulated the Botox and failed to warn consumers of the possibility that the toxin could spread outside the injection area and cause respiratory muscle paralysis.
Jeff Lowe, one of the St. Louis attorneys representing the plaintiff, noted, "Botulism is one of the most toxic substances known to man. My client suffers from botulism poisoning, a painful and terminal illness." The Lowe Law Firm, based in St. Louis, handles personal injury, medical malpractice, pharmaceutical liability, product liability and commercial cases throughout the United States.
SOURCE: The Lowe Law Firm CONTACT: The Lowe Law Firm Jeff Lowe, 314-678-3400 jeff@jefflowepc.com www.jefflowepc.com Copyright Business Wire 2009 -0- KEYWORD: United States
North America
Missouri INDUSTRY KEYWORD: Health
Alternative Medicine
Pharmaceutical
Professional Services
Legal
General Health SUBJECT CODE: Lawsuit


